June 17, 2019 Cell Analysis Tools Clinical Research/Diagn. Product Launch

Fluidigm Scales Highly Multiplexed Cell Analysis with Introduction of Seven New Metal Markers

Powering industry-leading CyTOF technology to deliver new insights in translational and clinical research SOUTH SAN FRANCISCO, Calif., June 17, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will introduce seven new cadmium metal labeling kits for mass cytometry in Q3. Representing... Read more

June 17, 2019 Clinical Research/Diagn. PR/Corporate

BD Announces New Leadership for BD Biosciences

Jun 17, 2019 San Jose, Calif., June 17, 2019 – BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the appointment of Puneet Sarin to worldwide president, BD Biosciences, effective today. In his new role, Puneet will be responsible for driving the global strategic, operational and commercial performance across BD Biosciences while advancing... Read more

June 13, 2019 Clinical Research/Diagn. Licensing, IP, and Legal

Bio-Techne Receives Approval to Offer the ExoDx™ Prostate IntelliScore™ (EPI) Test in New York State

JUNE 13, 2019 The EPI prostate biopsy rule-out test is now available in every state MINNEAPOLIS, June 13, 2019 /PRNewswire/ — Bio-Techne today announced that it has received a clinical laboratory permit from the New York State Department of Health to provide its ExoDx Prostate IntelliScore (EPI) test in New York, providing a valuable tool to help... Read more

June 12, 2019 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Saphetor SA and Swift Biosciences Announce Partnership to Standardize and Accelerate Data Interpretation for Targeted NGS Panels

Lausanne, June 12th, 2019 Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of bioinformatics solutions, announced today a partnership with Swift Biosciences Inc., a Michigan company based in Ann Arbor, USA, offering a set of differentiated next-generation sequencing (NGS) products and technologies for genomics, translational, and clinical research applications.... Read more

June 11, 2019 Acad, Gov/Utilities Atomic Spectroscopy Bio/Pharma/CRO Chromatography Clinical Research/Diagn. Lab Top-10

Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma (HNSCC)

Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma (HNSCC) PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify HNSCC patients for treatment with KEYTRUDA® (pembrolizumab) SANTA CLARA, Calif., June 11, 2019 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration... Read more

June 10, 2019 Atomic Spectroscopy Clinical Research/Diagn.

Roche and Spark Therapeutics, Inc. receive Request for Additional Information from FTC under Hart-Scott-Rodino Act and announce extension of tender offer for shares of Spark Therapeutics, Inc.

Basel, 10 June 2019 Roche and Spark Therapeutics, Inc. receive Request for Additional Information from FTC under Hart-Scott-Rodino Act and announce extension of tender offer for shares of Spark Therapeutics, Inc. Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that they have each received a request for additional... Read more

June 6, 2019 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Konica Minolta to Join Global Oncogenic Gene Panel Research

Move Strengthens Konica Minolta’s Advance into Personalized Medicine in Japan with Next-Generation Screening Capabilities Tokyo (June 6, 2019) – Konica Minolta, Inc. (Konica Minolta) today announces agreement with the University of Tokyo (UTokyo) and the National Cancer Center Japan (NCC) to research and develop the next generation Todai OncoPanel (TOP) , a world-leading oncogenic panel test.... Read more

June 6, 2019 Clinical Research/Diagn. M&A, Partnerships

bioMérieux increases its holding in Hybiome from 54% to 67%

06 June, 2019 bioMérieux, a world leader in the field of in vitro diagnostics, today announced an increase of its shareholding in Suzhou Hybiome Biomedical Engineering Co. Ltd. This announcement follows the earlier announcement of the acquisition of a majority stake in this company in November 2018. Founded in 2009 and located in Suzhou (China), Hybiome is specialized... Read more

June 5, 2019 Clinical Research/Diagn. Lab Top-10

Merck KGaA, Darmstadt, Germany, Opens Application Phase for Next Accelerator

05 JUN 2019 | DARMSTADT, GERMANY Start-ups can apply for programs at company headquarters in Darmstadt or in China Focus is on four fields: biosensing & interfaces, liquid biopsy technologies, clean meat, and artificial intelligence (AI)-enabled health solutions Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that that it has opened the next... Read more

June 5, 2019 Clinical Research/Diagn. M&A, Partnerships

QIAGEN and DiaSorin collaborate on novel QuantiFERON-based test with breakthrough potential for earlier detection of Lyme disease

Germantown, Maryland; Hilden, Germany and Saluggia, Italy, June 5, 2019 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE MIB: DIA) today announced the expansion of their QuantiFERON collaboration to develop an ultra-sensitive diagnostic test for Lyme disease, which is expected to address a significant unmet medical need. The companies plan multi-site clinical... Read more